MLSS

Mercury Analyzer Market worth $426 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期三, 五月 8, 2024
Opacity, Carbon, Hydrogen, Environmental monitoring, Hydrogen sulfide, PerkinElmer, Water, Gas, Soil, Electrochemistry, Public, Cox, Volatile organic compound, NOx, MLSS, Carbon dioxide, Teledyne Technologies, Statistics, Health, PEMS, CEMS, Oxygen, Oil, Digital, Atmosphere, Sulfur oxide, Carbon monoxide, Analytik Jena, Milestone, Region, Thermo Fisher Scientific, Mercury, Mining, Refinery, Growth, Coal

Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.

Key Points: 
  • Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.
  • Additionally, strict regulations aimed at reducing mercury emissions from industrial sources are driving the demand for mercury analyzers in this sector.
  • The Asia Pacific region for mercury analyzer industry is expected to grow at the highest CAGR during the forecast period.
  • In addition, governments are enforcing stricter emission standards, pushing industries to adopt mercury analyzers for monitoring and controlling mercury emissions .

Mercury Analyzer Market worth $426 million by 2029 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
星期三, 五月 8, 2024
Opacity, Carbon, Hydrogen, Environmental monitoring, Hydrogen sulfide, PerkinElmer, Water, Gas, Soil, Electrochemistry, Public, Cox, Volatile organic compound, NOx, MLSS, Carbon dioxide, Teledyne Technologies, Statistics, Health, PEMS, CEMS, Oxygen, Oil, Digital, Atmosphere, Sulfur oxide, Carbon monoxide, Analytik Jena, Milestone, Region, Thermo Fisher Scientific, Mercury, Mining, Refinery, Growth, Coal

Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.

Key Points: 
  • Furthermore, their versatility across different industries, such as healthcare, environmental monitoring, and mining, makes them a preferred choice for mercury analysis.
  • Additionally, strict regulations aimed at reducing mercury emissions from industrial sources are driving the demand for mercury analyzers in this sector.
  • The Asia Pacific region for mercury analyzer industry is expected to grow at the highest CAGR during the forecast period.
  • In addition, governments are enforcing stricter emission standards, pushing industries to adopt mercury analyzers for monitoring and controlling mercury emissions .

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida

Retrieved on: 
星期三, 四月 3, 2024
Johns Hopkins Hospital, MLSS, Anesthesia, Risk, Trauma, MD, ESI, CPT, ASC, Injection, Safety, Spine, Pain management, Pain, Physician, Epidural steroid injection, Nursing

ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida. PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers. PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.

Key Points: 
  • ROSELAND, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables into PRC Alliance Pain Relief Center at Ormond Beach, Florida.
  • PRC Alliance Pain Relief Centers operates 7offices and an ambulatory surgical center (ASC) located across Central Florida, with 15 providers.
  • PRC Alliance Pain Relief Centers is a family of pain management specialists who are dedicated to relieving pain through exceptional and compassionate care.
  • Adoption of the technology follows a successful evaluation by Dr. Sanjay Bakshi, MD, a pain management physician and CEO of PRC Alliance Pain Relief Centers in Ormond Beach, Florida.

Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023

Retrieved on: 
星期一, 四月 1, 2024
Growth, MLSS, Webcast, Telephone, Education, Dental Service Organizations, Operating cost, Hospital, United, CPT, Injection, Pain management, STA, Physician

Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial results in 2023, with revenue increasing 11.6% and gross profit increasing 39%.

Key Points: 
  • Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid financial results in 2023, with revenue increasing 11.6% and gross profit increasing 39%.
  • For the year ended December 31, 2023, international revenue was approximately $4.1 million, a decrease of $724,000 compared to December 31, 2022.
  • Gross profit for the year ended December 31, 2023, was $6.8 million versus $4.9 million for the year ended December 31, 2022.
  • Operating loss for the year ended December 31, 2023, was $7.1 million versus $8.8 million for the year ended December 31, 2022.

Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference Call

Retrieved on: 
星期四, 三月 28, 2024
Webcast, Telephone, MLSS, Injection

ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company’s financial results for 2023, as well as the company’s corporate progress and other developments

Key Points: 
  • ROSELAND, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Monday, April 1, 2024, to discuss the company’s financial results for 2023, as well as the company’s corporate progress and other developments
    The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 222156.
  • A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/50281 .
  • An audio replay of the call will be available through April 15, 2024, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and by entering the access code: 50281.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain Physicians

Retrieved on: 
星期四, 三月 14, 2024
MLSS, Patient, University, Chronic pain, ESI, Neck pain, Injection, Safety, Spine, Pain management, Physician, Epidural steroid injection, Dentistry

ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.

Key Points: 
  • ROSELAND, N.J., March 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables to Omaha Pain Physicians , a comprehensive medical pain management center in Omaha, NE.
  • Omaha Pain Physicians is focused on treating patients with acute and chronic pain.
  • Dr. Matthew Stottle completed 10 cases using the CompuFlo Epidural system at Omaha Pain Physicians, in which he reported 100% success.
  • The evaluation included Epidural Steroid Injection (ESI) procedures within the lumbar, thoracic and cervical thoracic junction of the spine.

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & Perio

Retrieved on: 
星期三, 二月 28, 2024
MLSS, Injection, Endodontics, Overalls, STA, Patient, Teaching, Periodontology, Dentistry

ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio , a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.

Key Points: 
  • ROSELAND, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced direct sales of its STA Single Tooth Anesthesia System® (STA) with Meridian Endo & Perio , a large endodontics, periodontics and implant dentistry practice with three offices in Wisconsin.
  • Dr. Lisa Teel, periodontist and implant surgeon with Meridian Endo and Perio, stated, “Our practice is committed to adopting the latest technologies to improve the overall patient experience.
  • Upon introduction, we were struck by the ease of use, as well as the STA’s ability to put patients at ease with dental anesthesia.
  • Moreover, we appreciate the ongoing educational and training support provided by Milestone Scientific.”
    Arjan Haverhals, Chief Executive Officer of Milestone Scientific, commented, “This latest agreement illustrates the benefits of our new direct sales model.

Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the Northeast

Retrieved on: 
星期二, 二月 20, 2024
MLSS, Injection, American Dental Association, Dentist, Marketing, DSO, STA, Dental Service Organizations, Patient, Dentistry

ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group , a premier group of 21 dental practices across the northeastern United States.

Key Points: 
  • ROSELAND, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announces it has commenced sales of its STA Single Tooth Anesthesia System® (STA) with Maine Dental Group , a premier group of 21 dental practices across the northeastern United States.
  • We are executing our new sales strategy, which allows us to leverage a lean sales organization, while providing a cost-effective means to scale the business.
  • According to the American Dental Association, approximately 23% of all dentists are now affiliated with group practices and DSOs.
  • We could not be more pleased with the STA, and plan on expanding its use within our group.”

Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update

Retrieved on: 
星期二, 一月 16, 2024
Patient, Injection, Traction, Health, Medicare, UTMB, Standard of care, Pain management, University, Spine, CPT, FDA, Physician, Letter, Epidural space, Patient safety, Education, MLSS, Pharmaceutical industry

I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.

Key Points: 
  • I am proud to report we are making steady progress in advancing commercialization of the CompuFlo technology.
  • Several advisory sites were established across the US that implemented the CompuFlo technology in their practice.
  • The medical decision by physicians to use CompuFlo demonstrates the clinical utility and benefit of the technology in patient care.
  • A review and analysis of claims data shared by providers indicated that roughly one-third of claims have already received positive payor reimbursement.

Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock

Retrieved on: 
星期三, 十二月 13, 2023
Telephone, Sale, Form, Injection, Attention, S-3, Prospectus, Security (finance), MLSS, Offering

ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”).

Key Points: 
  • ROSELAND, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the closing of its previously announced underwritten public offering of 4,765,000 shares of its common stock at a public offering price of $0.63 per share (the “Offering”).
  • Gross proceeds before deducting underwriting discounts, commissions and other Offering expenses were approximately $3.0 million.
  • The Company has granted the underwriter a 45-day option to purchase up to an additional 714,750 shares of common stock, on the same terms and conditions.
  • The shares of common stock were offered pursuant to a registration statement on Form S-3 (File No.